A Multi-center, Double-Blind, Randomized, Parallel-Group Trial to Compare the Efficacy and Safety of Three Doses of Meloxicam (7.5, 15, and 22.5 mg) and Placebo in Patients With Rheumatoid Arthritis
A Multi-center, Double-Blind, Randomized, Parallel-Group Trial to Compare the Efficacy and Safety of Three Doses of Meloxicam (7.5, 15, and 22.5 mg) and Placebo in Patients With Rheumatoid Arthritis
A 12-week trial consisting of 5 visits (6 if follow up is needed) to find out how effective and safe three different doses of meloxicam are compared with placebo in Rheumatoid Arthritis. Patient will take one dose of study medication daily.
Inclusion Criteria:
Exclusion Criteria:
Gainsville, Florida 32607, United States
Goiânia GO, 74043-011, Brazil
Porto Alegre RS, 90035-003, Brazil
São Paulo - SP, 04040-000, Brazil
São Paulo - SP, 04230-000, Brazil
Dnyepropetrovsk, 49044, Ukraine